Παρασκευή 19 Ιανουαρίου 2018

Venetoclax and obinutuzumab in chronic lymphocytic leukemia.

http:--highwire.stanford.edu-icons-exter https:--www.ncbi.nlm.nih.gov-corehtml-pm Related Articles

Venetoclax and obinutuzumab in chronic lymphocytic leukemia.

Blood. 2017 05 11;129(19):2702-2705

Authors: Fischer K, Al-Sawaf O, Fink AM, Dixon M, Bahlo J, Warburton S, Kipps TJ, Weinkove R, Robinson S, Seiler T, Opat S, Owen C, López J, Humphrey K, Humerickhouse R, Tausch E, Frenzel L, Eichhorst B, Wendtner CM, Stilgenbauer S, Langerak AW, van Dongen JJM, Böttcher S, Ritgen M, Goede V, Mobasher M, Hallek M

PMID: 28325865 [PubMed - indexed for MEDLINE]



http://ift.tt/2nUuS6a

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου